List all gene expressions in dataset HuLDa00010. The number is 3692.
First page Previous Next Last pageGene name |
Dataset name |
Gene expression |
alcohol dehydrogenase, iron containing, 1 | Copy number alterations of 103 hepatocellular carcinomas with hepatitis C virus etiology | Top 10% Copy Number Gain in liver cancer |
adiponectin receptor 1 | Copy number alterations of 103 hepatocellular carcinomas with hepatitis C virus etiology | Top 10% Copy Number Gain in liver cancer |
adenosine A1 receptor | Copy number alterations of 103 hepatocellular carcinomas with hepatitis C virus etiology | Top 10% Copy Number Gain in liver cancer |
adrenergic, beta-2-, receptor, surface | Copy number alterations of 103 hepatocellular carcinomas with hepatitis C virus etiology | Top 10% Copy Number Gain in liver cancer |
adenylosuccinate synthase | Copy number alterations of 103 hepatocellular carcinomas with hepatitis C virus etiology | Top 10% Copy Number Gain in liver cancer |
ATP/GTP binding protein-like 3 | Copy number alterations of 103 hepatocellular carcinomas with hepatitis C virus etiology | Top 10% Copy Number Gain in liver cancer |
acylglycerol kinase | Copy number alterations of 103 hepatocellular carcinomas with hepatitis C virus etiology | Top 10% Copy Number Gain in liver cancer |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) | Copy number alterations of 103 hepatocellular carcinomas with hepatitis C virus etiology | Top 10% Copy Number Gain in liver cancer |
alanine--glyoxylate aminotransferase 2 | Copy number alterations of 103 hepatocellular carcinomas with hepatitis C virus etiology | Top 10% Copy Number Gain in liver cancer |
AT hook containing transcription factor 1 | Copy number alterations of 103 hepatocellular carcinomas with hepatitis C virus etiology | Top 10% Copy Number Gain in liver cancer |
adenosylhomocysteinase-like 2 | Copy number alterations of 103 hepatocellular carcinomas with hepatitis C virus etiology | Top 10% Copy Number Gain in liver cancer |
axin interactor, dorsalization associated | Copy number alterations of 103 hepatocellular carcinomas with hepatitis C virus etiology | Top 10% Copy Number Gain in liver cancer |
absent in melanoma 2 | Copy number alterations of 103 hepatocellular carcinomas with hepatitis C virus etiology | Top 10% Copy Number Gain in liver cancer |
aldo-keto reductase family 1, member B1 (aldose reductase) | Copy number alterations of 103 hepatocellular carcinomas with hepatitis C virus etiology | Top 10% Copy Number Gain in liver cancer |
aldo-keto reductase family 1, member B10 (aldose reductase) | Copy number alterations of 103 hepatocellular carcinomas with hepatitis C virus etiology | Top 10% Copy Number Gain in liver cancer |
aldo-keto reductase family 1, member B15 | Copy number alterations of 103 hepatocellular carcinomas with hepatitis C virus etiology | Top 10% Copy Number Gain in liver cancer |
v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) | Copy number alterations of 103 hepatocellular carcinomas with hepatitis C virus etiology | Top 10% Copy Number Gain in liver cancer |
aldehyde dehydrogenase 7 family, member A1 | Copy number alterations of 103 hepatocellular carcinomas with hepatitis C virus etiology | Top 10% Copy Number Gain in liver cancer |
aldehyde dehydrogenase 9 family, member A1 | Copy number alterations of 103 hepatocellular carcinomas with hepatitis C virus etiology | Top 10% Copy Number Gain in liver cancer |
alpha-methylacyl-CoA racemase | Copy number alterations of 103 hepatocellular carcinomas with hepatitis C virus etiology | Top 10% Copy Number Gain in liver cancer |